Benzene Ring Containing Patents (Class 514/730)
-
Publication number: 20100130620Abstract: The present invention is directed to the use of (a composition comprising) hydroxytyrosol for treating or preventing age-related macular degeneration in humans, for maintaining the eye health in animals (preferably in humans), especially in elderly animals (preferably elderly humans), for improving the vision of animals (preferably of humans), for maintaining the high resolution vision in animals (preferably in humans) and/or for maintaining the visual acuity in animals (preferably in humans), as well as for maintaining the visual performance in animals (preferably in humans) and/or the visual function in animals (preferably in humans).Type: ApplicationFiled: April 18, 2007Publication date: May 27, 2010Inventors: Jiankang Liu, Wolfgang Schalch, Ying Wang-Schmidt, Karin Wertz
-
Patent number: 7718830Abstract: The present invention provides a method of treating glaucoma or ocular hypertension which comprises applying to the eye of a person in need thereof an amount sufficient to treat glaucoma or ocular hypertension of a compound of formula I wherein Y, Q, Z, R, R1 and R2 are as defined in the specification. The present invention further comprises pharmaceutical compositions, e.g. ophthalmic compositions, including said compound of formula I.Type: GrantFiled: April 24, 2006Date of Patent: May 18, 2010Assignee: Allergan, Inc.Inventors: June Chen, Simon Pettit, Hans Fliri
-
Publication number: 20100120919Abstract: Kinetic stabilization of the native state of transthyretin is an effective mechanism for preventing protein misfolding. Because transthyretin misfolding plays an important role in transthyretin amyloid diseases, inhibiting such misfolding can be used as an effective treatment or prophylaxis for such diseases. Treatment methods are disclosed.Type: ApplicationFiled: June 9, 2009Publication date: May 13, 2010Inventors: Jeffery W. Kelly, Evan T. Powers, Hossein Razavi
-
Publication number: 20100056645Abstract: Buffered antimicrobial solutions of benzyl alcohol and ethanol and their use for short or long term storage of chromatographic solids.Type: ApplicationFiled: December 10, 2007Publication date: March 4, 2010Inventors: Nandu Deorkar, Steve Magee
-
Patent number: 7666254Abstract: A wood preservation composition comprising an unexpectedly efficacious combination of a boron compound and bifenthrin is disclosed. A method of preserving wood, as well as the preserved wood, are also disclosed.Type: GrantFiled: August 20, 2007Date of Patent: February 23, 2010Assignee: Osmose, Inc.Inventors: Francisco Javier Romero Amaya, Jun Zhang
-
Patent number: 7632523Abstract: An enhanced activity aqueous disinfecting solution having a pH of from about 0.5 to about 6 and consisting essentially of (i) hydrogen peroxide in a concentration of from about 0.Type: GrantFiled: September 11, 2006Date of Patent: December 15, 2009Assignee: Virox Technologies Inc.Inventors: Jose A. Ramirez, Navid Omidbakhsh
-
Patent number: 7625950Abstract: Compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, X, Y and n are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.Type: GrantFiled: April 29, 2004Date of Patent: December 1, 2009Assignee: Novartis AGInventors: Klaus Hinterding, Carsten Spanka, Frédéric Zecri
-
Publication number: 20090274720Abstract: A fat-soluble fraction extracted from the fruiting body of Hericium erinaceum is demonstrated to inhibit the neuronal toxicity of amyloid beta-peptide (A?) and induce the synthesis of nerve growth factor (NGF), and has great potential as an active ingredient for pharmaceutical products, health food products, food products and/or beverages to prevent and/or treat dementia, especially Alzheimer-type dementia. This invention is to provide the bioactive fraction and its preparation method.Type: ApplicationFiled: May 2, 2008Publication date: November 5, 2009Inventors: Cun Zhuang, Hirokazu Kawagishi, Luyong Zhang, Hideo Anzai
-
Publication number: 20090209656Abstract: The present invention relates to a method for disinfection or sanitation of different material, especially sensitive material, such as chromatographic media with various sensitive ligands. The invention also relates to a composition for use in such a method. The method for disinfection/sanitation, comprises exposing the material to be treated to a solution comprising 5-10% benzyl alcohol and 10-30% C2-3 alcohol.Type: ApplicationFiled: June 12, 2007Publication date: August 20, 2009Applicant: GE HEALTHCARE BIO-SCIENCES ABInventor: Hamid Houshmand
-
Patent number: 7553834Abstract: A method for determining the appropriate medication for a patient suffering from depression. A patient will take a questionnaire wherein the patient answers a number of questions with scaled responses concerning the degree to which the patient's mental state is affected by at least one or both of impaired modulation and impaired activation. Next, the patient's answers will be processed to arrive at scores for the at least one impaired modulation and impaired activation. Depending upon the patient's scores for demodulation and deactivation, at least one medication which affects the at least one impaired modulation and impaired activation is recommended.Type: GrantFiled: July 19, 2002Date of Patent: June 30, 2009Inventor: Richard J. Metzner
-
Publication number: 20090163601Abstract: This invention is directed to enantiomerically enriched (R)-2-methyl-(2,5-dimethylphenyl)propanol and (S)-2-methyl-(2,5-dimethylphenyl)propanol. The chiral alcohols are synthesized in enantiomerically enriched form by the reaction of 2-methyl-(2,5-dimethylphenyl)propanone using a chiral oxazaborolidine catalyst.Type: ApplicationFiled: December 21, 2007Publication date: June 25, 2009Inventors: Matthew P. Meyer, Jason West
-
Patent number: 7544349Abstract: There are described personal care compositions containing a) one or more dibenzoylmethane sunscreening agents; and b) a photostablising amount of a salicylate ester of formula (1): (2-OH)Ph-(CO)—O—R, wherein R represents an alkyl group consisting of a chain of from 7 to 16 carbon atoms substituted by at least one group selected from methyl and ethyl. The compound of formula (1) is preferably isodecyl salicylate or isotridecyl salicylate. The salicylate esters of formula (1) have a stabilizing effect on the compositions. The salicylate esters prevent or inhibit degradation of the sunscreening agents which would otherwise lead to a reduction in the efficacy of the sunscreening agents and an increase in the deleterious effects of exposure to sunlight on the user of the compositions or on the compositions themselves.Type: GrantFiled: July 31, 2002Date of Patent: June 9, 2009Assignee: The Boots Company, PLCInventors: Jane Evison, Janet Palin, Edward Galley
-
Patent number: 7537777Abstract: Synergistic and residual pesticidal compositions containing synergistic and residual mixtures of plant essential oils and/or their constituents, plant essential oils and/or their constituents in admixture with known active pesticidal compounds or plant essential oils and/or their constituents in admixture with other compounds not previously used as active ingredients in pesticidal formulations, such as, for example, so called signal transduction modulators. In addition, the present invention is directed to a method for controlling pests by applying a pesticidally effective amount of the above synergistic and residual pesticidal compositions to a locus where pest control is desired.Type: GrantFiled: July 30, 2007Date of Patent: May 26, 2009Assignee: Ecosmart Technologies, Inc.Inventors: Steven M. Bessette, Myron A. Beigler
-
Publication number: 20090061048Abstract: A complex coacervate delivery system is provided which encapsulates lipophilic nutrients such as, for example, fish oils high in omega-3 fatty acids. The complex coacervate delivery system protects the lipophilic nutrient from degradation, e.g., oxidation and hydrolysis, and also reduces or eliminates the unpleasant taste and odor of the lipophilic nutrient. The complex coacervate delivery system upon ingestion is operative to substantially release the lipophilic nutrient in the lower gastrointestinal tract in a pH-controlled manner. The complex coacervate delivery system may be included in a food or beverage product having a pH value within the range of about 1.5 to about 5.0.Type: ApplicationFiled: August 28, 2007Publication date: March 5, 2009Applicant: PepsiCo, Inc.Inventors: Daniel S. Kohane, Yoon Yeo, Peter Given, Robert S. Langer
-
Publication number: 20090036544Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of POH, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with POH as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing POH in particular formulations, and POH with a second compound that also exerts an effect on the androgen receptor.Type: ApplicationFiled: October 18, 2007Publication date: February 5, 2009Inventor: Charles Y. F. Young
-
Patent number: 7485669Abstract: The invention relates to a pharmaceutical composition comprising at least one phenol derivative represented by formula (I) wherein R1 represents a hydrogen atom, a halogen atom or a hydrocarbon group containing up to 12 carbon atoms; R2 represents a hydrogen atom or a C1-C7 alkyl group; wherein R1 and R2 may optionally form a carbocyclic 5- or 6-membered ring; R3 represents a hydrogen atom, a halogen atom or a C1-C7alkyl group; R4 represents a hydrogen atom, a C1-C7 alkyl group or a halogen atom; R5 represents hydrogen atom, a halogen atom or a C1-C7 alkyl group; and R6 represents a hydrogen atom, a C1-C7 alkyl group or a C2 or C3 alkenyl group, under the proviso that R2 and R4 can only both represent a hydrogen atom if both R1 and R5 represent a C1-C7 alkyl group and R3 represents a halogen atom.Type: GrantFiled: November 13, 2001Date of Patent: February 3, 2009Assignee: B. Braun Melsungen AGInventors: Gertrud Haeseler, Martin Leuwer
-
Publication number: 20090028895Abstract: A dietary supplement composition comprising a therapeutically effective amount of at least one sirt 1 activating agent, a therapeutically effective amount of at least one Qi activating agent, and a therapeutically effective amount of at least one adaptogen is disclosed. An optional herbal treatment for stress-related deep wrinkles comprises chronic oral administration for at least two weeks of a beverage containing an effective amount of a valerian root extract sufficient to provide a desired reduction in the appearance of the deep wrinkles. A photoprotective agent may also be included. Also included are a microcirculation increasing agent. Also optional are an herbal toner and topical cellulite product.Type: ApplicationFiled: November 29, 2007Publication date: January 29, 2009Inventor: Walter P. Smith
-
Publication number: 20090023628Abstract: The present invention relates to a cosmetic composition comprising: a wetting system that comprises at least glycerin in an amount ranging from 8.0% to 10% by weight, based on the total weight of the composition; an emollient system that comprises at least cetyl lactate and Shea butter; an emulsifying system that comprises at least steareth-2 and steareth-21; an oiliness adsorbing system that comprises at least nylon 12; and a silicone system that comprises at least cyclomethicone and cyclomethicone and dimethicone crosspolymer. This multifunctional cosmetic composition exhibits rapid absorption, properties of differentiated softness, smoothness and intensive and prolonged hydration when applied to the skin. Further, the present invention relates to a process of preparing the referred-to cosmetic composition and to a cosmetic product that comprises said composition.Type: ApplicationFiled: December 28, 2005Publication date: January 22, 2009Inventors: Luciana Villa Nova Silva, Alexandre Roberto Silva, Thiago Braz
-
Publication number: 20090023815Abstract: A process for preparing Tyrosol and/or Hydroxytyrosol from oil mill wastewaters. includes: a) Microfiltration (MF), Ultrafiltration (UF), Nanofiltration (NF) and Reverse Osmosis (RO) of the OMW; b) Separation of Tyrosol, Hydroxytyrosol and other phenolic compounds from the concentrated RO; c) Oxidation of the obtained Tyrosol to Hydroxytyrosol in the presence of methyl rhenium trioxide and of hydrogen peroxide in a protic solvent.Type: ApplicationFiled: May 14, 2008Publication date: January 22, 2009Applicant: LACHIFARMA S.R.L LABORATORIO CHIMICO FARMACEUTICO SALENTINOInventors: Luigi Villanova, Luciano Villanova, Gianluca Fasiello, Alessandro Merendino
-
Publication number: 20080312333Abstract: The present invention has its object to provide an agent for preventing and/or ameliorating life style-related diseases which contains, as an active ingredient, a substance derived from a safe food material having a long history of being eaten as a food and which is capable of being utilized as functional foods such as health foods or functional health foods (specific health foods, functional nutritive foods). The agent for preventing and/or ameliorating life style-related diseases according to the invention contains, as an active ingredient, at least one compound selected from the group consisting of ar-turmerone, ?-turmerone, ?-turmerone, curlone, bisacumol and ?-sesquiphellandrene, or at least one compound selected from among the bisabolane type sesquiterpenoids derived from Curcuma longa L., and therefore is useful for preventing and/or ameliorating diabetes, visceral fat obesity, metabolic syndrome and obesity, among others.Type: ApplicationFiled: May 30, 2005Publication date: December 18, 2008Applicant: Kaneka CorporationInventors: Tatsumasa Mae, Tozo Nishiyama, Hideyuki Kishida, Ryoji Takagaki, Masaji Yamamoto
-
Publication number: 20080312195Abstract: The invention relates to clear, liquid preservatives, which contain a) one or several 1-hydroxy-4-methyl-6-alkyl-2(1H)-pyridones and/or one or several salts thereof. wherein alkyl represents a linear, branched or cyclic alkyl group having 1-12 carbon atoms, and b) one or several alcohols containing one or several aromatic groups.Type: ApplicationFiled: January 25, 2006Publication date: December 18, 2008Applicant: CLARIANT PRODUKTE (DEUTSCHLAND) GMBHInventors: Waltraud Simsch, Peter Klug, Sonja Klein
-
Publication number: 20080312186Abstract: The present invention pertains to certain ketones and reduced ketones and derivatives thereof which, inter alia, inhibit osteoclast survival, formation, and/or activity; and/or inhibit bone resorption, and more particularly to compounds of the formulae and pharmaceutically acceptable salts, amides, esters, and ethers thereof, wherein: Ar1, Ralk, —ORO, and -Q are as defined herein: The present invention also pertains to pharmaceutical compositions comprising such compounds. The compounds inhibit osteoclast survival, formation, and/or activity, and inhibit conditions mediated by osteoclasts and/or characterised by bone resorption, and are useful in the treatment of bone disorders such as osteoporosis, rheumatoid arthritis, cancer associated bone disease, Paget's disease, aseptic loosening of prosthetic implants, and the like; and/or in the treatment of conditions associated with inflammation or activation of the immune system.Type: ApplicationFiled: August 19, 2008Publication date: December 18, 2008Applicant: The University Court of the University of AberdeenInventors: Stuart H. RALSTON, Iain R. GREIG, Aymen I. I. MOHAMED, Robert J. VAN 'T HOF
-
Publication number: 20080275016Abstract: Compounds, pharmaceutical compositions including the compounds, and methods of preparation and use thereof are disclosed. The compounds are fulvene and/or fulvalene analogs. The compounds and compositions can be used to treat and/or prevent a wide variety of cancers, including drug resistant cancers, as well as numerous inflammatory, degenerative and vascular diseases, including various ocular diseases. Representative fulvene and/or fulvalene analogs include fulvene and fulvalene analogues of various dyes, hormones, sugars, peptides, oligonucleotides, amino acids, nucleotides, nucleosides, and polyols. The compounds are believed to function, at least, by inhibiting Nox or ROS. In some embodiments, the Nox is one that is selectively expressed in cancer cells over normal cells, or one that is expressed in higher amounts in cancer cells over normal cells. Thus, the compounds are novel therapeutic agents for a variety of cancers and other diseases.Type: ApplicationFiled: May 2, 2008Publication date: November 6, 2008Inventor: Jack L. Arbiser
-
Publication number: 20080267904Abstract: Antimicrobial compositions having a rapid antiviral and antibacterial effectiveness, and a persistent antiviral effectiveness, are disclosed. The antimicrobial compositions contain a phenolic antimicrobial agent, a surfactant, a hydrotrope, a hydric solvent, and an organic acid, wherein the phenolic antimicrobial agent is present in a continuous aqueous phase in an amount of at least 25% of saturation concentration and the composition has a pH of about 5 or less.Type: ApplicationFiled: December 5, 2005Publication date: October 30, 2008Applicant: THE DIAL CORPORATIONInventors: Timothy J. Taylor, Richard F. Theiler, Earl P. Seitz
-
Patent number: 7438923Abstract: Synergistic and residual pesticidal compositions containing synergistic and residual mixtures of plant essential oils in admixture with enzyme inhibitors, with or without other compounds not previously used as active ingredients in pesticidal formulations. In addition, the present invention is directed to a method for controlling pests by applying a pesticidally-effective amount of the above synergistic and residual pesticidal compositions to a locus where pest control is desired.Type: GrantFiled: October 31, 2005Date of Patent: October 21, 2008Assignee: Ecosmart Technologies, Inc.Inventor: Steven M. Bessette
-
Patent number: 7419998Abstract: Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (I), in which Z is H, R1 is H, or RACO where RA is C1-10alkyl or an amino acid, R2 is H, OH, or ORB where RB is an amino acid, or CORA where RA is as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein R3 is H, CORA where RA is as previously defined, CO2RC where RC is C1-10alkyl, or CORB where RB is as previously defined, R4 is H, CORD where RD is H, OH, C1-10alkyl or an amino acid, CO2RC where RC is as previously defined, CORE where RE is H.Type: GrantFiled: December 28, 2004Date of Patent: September 2, 2008Assignee: Novogen Research Pty LtdInventors: Graham Edmund Kelly, George Eustace Joannou
-
Publication number: 20080193512Abstract: An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.Type: ApplicationFiled: December 22, 2005Publication date: August 14, 2008Applicant: Sapporo Medical UniversityInventors: Yoshiro Niitsu, Junji Kato, Yasushi Sato
-
Patent number: 7390838Abstract: The present invention is directed to crystalline forms of anhydrous 4-cyclopentyl resorcinol, the Form A and C polymorphs, formulations containing at least one of these crystalline forms and their use to lighten skin.Type: GrantFiled: May 19, 2004Date of Patent: June 24, 2008Assignee: Pfizer Inc.Inventor: William Thomas Gattrell
-
Patent number: 7384920Abstract: This invention relates to a new use of stilbene derivatives or pharmaceutically acceptable salts thereof, especially in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus associated diseases.Type: GrantFiled: July 26, 2001Date of Patent: June 10, 2008Assignees: Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA, Beijing Luyin Lihua Pharmaceutical Science and Technology Development Company LtdInventors: Junlin Li, Zuze Wu, Lizhen Yuan, Qiang Li, Zhongxiong Tang
-
Publication number: 20080102109Abstract: This invention concerns novel methods of enhancing the solubility of a compound. Compositions prepared using such methods are also disclosed. Compositions prepared using the methods have various advantages over conventionally known compositions.Type: ApplicationFiled: October 27, 2006Publication date: May 1, 2008Inventors: John G. Augustine, Kaliappanadar Nellaiappan, Benjamin S. Isaacs, Indu J. Isaacs
-
Publication number: 20080070971Abstract: Formulations and methods for preventing, inhibiting or controlling metabolic disorder, age-related disease and acute inflammations have been developed. The compositions comprise of bilirubins, bilirubin derivatives, their tetrapyrrolic analogues, tripyrroles, and dipyrroles. The compositions can be administered as a dosage form for oral ingestion, injection, suppository, or topical application. The effective amount of the compound is typically from 0.001-100 mg/kg body weight, preferably in the range from 0.01-50 mg/kg body weight, and most preferably from 0.05-10 mg/kg body weight. Examples demonstrate the efficacy of the compounds in both in vitro and in vivo tests.Type: ApplicationFiled: March 6, 2007Publication date: March 20, 2008Inventor: Xiang H. Wang
-
Publication number: 20080057098Abstract: The present invention relates to new use of inhibitors of bcl-2/bcl-XI family of anti-apoptotic compounds for the treatment of post-angioplasty restenosis and in-stent restenosis. Small molecules of Bcl inhibitors are incorporated into a stent, typically by a fine polymeric coating over the metal, which would be placed during angioplasty of occluded blood vessels, to act on fibroproliferative in-growth. Hollow organs such as urethras, Fallopian tubes and vascular access grafts could be treated in a similar manner to prevent their closure due to fibrosis. Other iatrogenic fibrosis such as adhesions after surgery could also be blocked by this therapy.Type: ApplicationFiled: August 31, 2007Publication date: March 6, 2008Inventors: Timothy A. McCaffrey, Zhaoqing Yang, Dmitri Gagarin
-
Patent number: 7338979Abstract: The present invention is directed to 4-cyclopentyl resorcinol monohydrate, its Form I polymorph, formulations containing at least one of these compounds, and their use to lighten skin.Type: GrantFiled: January 28, 2004Date of Patent: March 4, 2008Assignee: Warner-Lambert CompanyInventors: Martin James Procter, William Thomas Gattrell
-
Patent number: 7326735Abstract: A formulation for anaesthetic use is described. The formulation contains propofol, and may be used to induce and/or maintain anaesthesia or sedation in a vertebrae. The formulation additionally contains a solvent or a combination of solvents and is suitable for mixing with commonly used infusion fluids prior to injection in to a patient. The formulation may be terminally sterilised using moist heat in order to assure sterility, and contains no lipid, thereby avoiding complications associated with administration over prolonged periods of time, or to patients with disorders of fat metabolism.Type: GrantFiled: April 28, 2004Date of Patent: February 5, 2008Assignee: Parnell Laboratories (Aust) Pty LimitedInventors: Alan R. Bell, Fenella Cochrane, Geoffrey N. O'Connor, James S. Rowe
-
Patent number: 7323187Abstract: The invention relates to a method for impregnating, incorporating or surface-treating substances/articles that can be microbially decomposed, contaminated and/or infested with parasites and/or that are perishable. The inventive method comprises the following steps: applying a special antimicrobial/antiparasite composition on the substances/articles or incorporating the antimicrobial/antiparasite composition in the substances. The invention further relates to said special antimicrobial/antiparasite compositions, to their use for impregnating and/or surface-treating substances that can be microbially decomposed, contaminated and/or that are perishable or substances that are infested with parasites and to the use thereof in substances and products that have to be self-contaminating.Type: GrantFiled: August 28, 2000Date of Patent: January 29, 2008Inventor: Jörg Peter Schür
-
Patent number: 7312249Abstract: Novel biaromatic vitamin D analogues have the general formula (I): and are suited for a wide variety of pharmaceutical applications, whether in human or veterinary medicine, and also for cosmetic applications.Type: GrantFiled: February 28, 2005Date of Patent: December 25, 2007Assignee: Galderma Research & DevelopmentInventors: Thibaud Biadatti, Etienne Thoreau, Johannes Voegel, Andre Jomard
-
Patent number: 7294342Abstract: Water-soluble or water-dispersible, substantially air-impermeable, pharmacologically acceptable, liquid barrier compositions for treating ectoparasite infestations on animal skin and hair, wherein the compositions contain at least one monohydric aralkyl alcohol to prevent the ectoparasites from closing their respiratory systems, and wherein the compositions are free from pesticides.Type: GrantFiled: January 4, 2003Date of Patent: November 13, 2007Assignee: Summers Laboratories, Inc.Inventor: Michael J Precopio
-
Patent number: 7268165Abstract: Antimicrobial compositions which can be used wherever disinfecting compositions are needed, such as in a hospital, healthcare industry, workplace, recreational facility, home or similar environment. The antimicrobial compositions are particularly useful as a topical application for a substrate, such as skin and can be used as a hand sanitizer or pre-surgical scrub. The compositions comprise a synergistic combination of a simple aliphatic alcohol and an activity enhancing substance, wherein the composition provides, heretofore unexpected, persistent activity against a broad range of microorganisms, including gram-negative organisms, while moisturizing the skin.Type: GrantFiled: August 20, 2004Date of Patent: September 11, 2007Assignee: Steris Inc.Inventors: Zachariah C. Greten, Nancy-Hope E. Kaiser, Daniel A. Klein
-
Publication number: 20070190190Abstract: Compositions and methods of treating skin irritation are disclosed where a conditioning composition is applied to the skin of a user. The compositions and methods are useful to prevent, reduce and/or eliminate irritation of the skin subjected to topical treatment.Type: ApplicationFiled: December 30, 2006Publication date: August 16, 2007Inventors: Jose E. Ramirez, Joseph Faryniarz
-
Patent number: 7226610Abstract: Non-toxic, naturally derived and economical compositions for treating and preventing bacterial or fungal disease in plants, especially citrus canker, wherein such compositions include various combinations of d-limonene, wax and monohydric alcohol are provided. Methods for making and using such compositions are also provided.Type: GrantFiled: March 30, 2005Date of Patent: June 5, 2007Assignee: Preservation Sciences, Inc.Inventor: Paul Winniczuk
-
Patent number: 7223736Abstract: The present invention relates to methods and nutritional compositions for the prevention and treatment of cachexia and anorexia. The methods of the invention comprise administering a composition comprising effective amounts of ?-3 fatty acids such as alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid or mixtures thereof; of branched-chain amino acids valine, leucine, isoleucine or mixtures thereof; with or without reduced levels of tryptophan and 5-hydroxytryptophan; and of antioxidant system selected from the group comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof.Type: GrantFiled: February 23, 2004Date of Patent: May 29, 2007Assignee: Abbott LaboratoriesInventors: Bonnie Chandler Abbruzzese, Mark Anthony McCamish, Frederick Oliver Cope, Stephen Joseph DeMichele
-
Patent number: 7220784Abstract: The present invention relates to stilbene and quinone compounds related to combretastatin A-4 and their use as anticancer compounds and prodrugs. The compounds include those with an alkyl group on the double bond of cis or trans-stilbenes, compounds with one or more (and preferably 2 or 3) alkyl group substituents on the stilbene A ring, compounds with an alkoxy group other than methoxy at position 3, 4, and/or 5 of the stilbene A ring, compounds (or prodrugs) in which BOC amino acid esters are formed with the phenolic hydroxyl at the 3-position of the B ring and compounds (or prodrugs) based on a benzoquinone B ring. The present invention further relates to the photochemical reactions of stilbene compounds, either the above compounds disclosed for the first time herein or compounds based on prior art stilbenes.Type: GrantFiled: December 20, 2001Date of Patent: May 22, 2007Inventors: John Anthony Hadfield, Alan Thomson McGown, Stephen Patrick Mayalarp, Edward John Land, Ian Hamblett, Keira Gaukroger, Nicholas James Lawrence, Lucy Annette Hepworth, John Butler
-
Patent number: 7202273Abstract: Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (1), in which Z is H, R1 is H, or RACO where RA is C1-10alkyl or an amino acid, R2 is H, OH, or ORB where RB is an amino acid, or CORA where RA is as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein R3 is H, CORA where RA is as previously defined, CO2Rc where RC is C1-10alkyl, or CORB where RB is as previously defined, R4 is H, CORD where RD is H, OH, C1-10alkyl or an amino acid, CO2RC where RC is as previously defined, CORE where RE is H, C1-10alkyl or an amino acid, COOH, CORC where RC is as previously defined, or CONHRE where RE is as previously defined, R5 is H, CORC whereType: GrantFiled: June 21, 2002Date of Patent: April 10, 2007Assignee: Novogen Research Pty LtdInventors: Graham Edmund Kelly, George Eustace Joannou
-
Patent number: 7189759Abstract: The present invention addresses the problem of excessive discoloration in hydroquinone compositions of a neutral pH. Antioxidants in the hydroquinone phase and inorganic or amino acyl cationic salts of acidic ascorbyl esters, preferably sodium metabisulfite and magnesium ascorbyl phosphate respectively, are effective in stabilizing such hydroquinone compositions, which are used in treatment of pigmentation disorders. Protected retinoid may be added to these compositions for additional skin benefit effects.Type: GrantFiled: May 23, 2001Date of Patent: March 13, 2007Assignee: Medicis Pharmaceutical CorporationInventors: Mitchell S. Wortzman, Philip J. Gordon, Eugene H. Gans, Bhiku G. Patel
-
Patent number: 7157078Abstract: This invention relates to devices, kits, and methods for eliminating termite colonies. The kits, devices, and methods employ a termiticidal bait matrix containing a) a termiticide selected such that the termiticide causes death to about 50 to about 100% of termites within about 24 to about 84 days after the termites begin to ingest the termiticide or the bait matrix comprising the termiticide, b) a cellulose containing material, and c) water. The termiticidal bait matrix can be used in a bait station installed in the ground. The kits are suitable to be used by consumers in their homes.Type: GrantFiled: February 2, 2004Date of Patent: January 2, 2007Assignee: The University of Florida Research Foundation, Inc.Inventors: Philip Frederick Brode, III, Garry Steven Garren, Leo Timothy Laughlin, Randall Stryker Matthews, Dale Edwin Barker, Daniel James Kinne, Gary Eugene McKibben, Christopher Miles Miller, Timothy Robert Probst
-
Patent number: 7119123Abstract: Antimicrobially active 4-methyl-4-aryl-2-pentanols of the Formula 1 below, methods for the preparation of these compounds and their use as antimicrobial active compounds are described. Surprisingly, compounds of the Formula 1 for which: R=hydrogen, hydroxyl, alkoxy group with up to 10 C atoms, straight-chain or branched, saturated or unsaturated alkyl with up to 10 C atoms, alkylthioether group with up to 10 C atoms, the alkylthioether group being bonded to the aromatic ring via a thioether bridge, fluorine, chlorine, bromine, iodine, or alkyl with up to 10 C atoms that is interrupted by one or more oxygen and/or sulphur atoms, have proved to be antimicrobially active.Type: GrantFiled: March 3, 2004Date of Patent: October 10, 2006Assignee: Symrise GmbH & Co. KGInventors: Gerhard Schmaus, Holger Joppe
-
Patent number: 7109164Abstract: New thyroid receptor ligands are provided which have the general formula in which: X is —O—, —S—, —CH2—, —CO—, or —NH—; Y is —(CH2)n— where n is an integer from 1 to 5, or cis- or trans-ethylene; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 4 carbons or cycloalkyl of 3 to 6 carbons, at least one of R2 and R3 being other than hydrogen; R4 is hydrogen or lower alkyl; R5 is hydrogen or lower alkyl; R6 is carboxylic acid, or esters or prodrugs; R7 is hydrogen or an alkanoyl or an aroyl. In addition, a method is provided for preventing, inhibiting or treating a disease associated with metabolism dysfunction or which is dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.Type: GrantFiled: August 30, 2004Date of Patent: September 19, 2006Assignee: Bristol-Myers Squibb CompanyInventors: Todd J. Friends, Denis E. Ryono, Minsheng Zhang
-
Patent number: 7109240Abstract: Disclosed is a method for killing or controlling invertebrates comprising applying a pesticidally-effective amount of a pesticidal composition to invertebrates or to a locus where killing or control of invertebrates is desired, wherein (i) the invertebrates are selected from the group consisting of ants, cockroaches, spiders, fleas, ticks, earwigs, pillbugs, beetles, flies, crickets, mosquitoes, and wasps, and (ii) the pesticidal composition is unscented and comprises an inert carrier and a pesticidally active ingredient consisting of benzyl alcohol and phenethyl propionate.Type: GrantFiled: March 29, 2004Date of Patent: September 19, 2006Assignee: Ecosmart Technologies, Inc.Inventors: Steven M. Bessette, Arthur M. Knight
-
Patent number: 7090831Abstract: The present invention relates to novel pharmaceutical aerosol formulations comprising: (A) salmeterol xinafoate in the form of particles coated by spray-drying with at least one surfactant in the absence of any other coating excipient, in suspension in (B) a liquefied propellant gas which is 1,1,1,2,3,3,3-heptafluoro-n-propane or 1,1,1,2-tetrafluoroethane and mixtures thereof for administration particularly by the pulmonary route and to a process for preparing these formulations. It also relates to novel particles suitable for use in such formulations.Type: GrantFiled: April 13, 2000Date of Patent: August 15, 2006Assignee: SmithKline Beecham CorporationInventors: Cecile Isabelle Bonvoisin, Christophe Laroche
-
Patent number: 7081477Abstract: The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.Type: GrantFiled: August 12, 2004Date of Patent: July 25, 2006Assignee: The Children's Medical Center CorporationInventors: Robert John D'Amato, Moses Judah Folkman